IR officer Andrew Schiesl awarded RSUs and options; $76.48 strike
Rhea-AI Filing Summary
Andrew R. Schiesl, Senior Vice President, General Counsel, Chief Compliance Officer and Secretary of Ingersoll Rand Inc. (IR), acquired equity awards on 08/06/2025 consisting of 1,470 restricted stock units (RSUs) and 3,602 stock options. The Form 4 reports these as acquisitions and shows the holdings as directly beneficially owned.
The RSUs vest in four equal annual installments beginning on 08/06/2026 and will be settled in shares, cash, or a combination. The stock options also vest in four equal annual installments beginning on 08/06/2026, carry an exercise price of $76.48, and expire on 08/06/2035. Following these grants, the report lists 1,470 RSUs and 3,602 options beneficially owned.
Positive
- 1,470 restricted stock units (RSUs) awarded
- 3,602 stock options awarded with a $76.48 exercise price expiring on 08/06/2035
- Vesting schedule stated: both RSUs and options vest in four equal annual installments beginning on 08/06/2026
- Holdings reported as direct beneficial ownership
Negative
- None.
Insights
TL;DR: Routine executive equity grants reported as direct ownership with standard multi-year vesting; transaction appears procedural.
The Form 4 documents an officer-level grant to Andrew Schiesl that increases his direct beneficial holdings by 1,470 RSUs and 3,602 stock options. Vesting for both award types begins on 08/06/2026 in four equal annual instalments, a common schedule for retention and alignment. The options carry a stated exercise price of $76.48 and expire on 08/06/2035. Based on the filing alone, this is a standard compensation grant disclosed under Section 16 reporting rules.
TL;DR: Compensation award combines RSUs and ten-year options with identical vesting start dates; terms are explicit in the filing.
The filing shows two award types: 1,470 RSUs that will be settled in shares, cash, or both, and 3,602 stock options with a $76.48 exercise price and an expiration date of 08/06/2035. Both awards vest in four equal annual instalments beginning 08/06/2026. These are recorded as direct holdings following the acquisition. The disclosure is concise and identifies grant mechanics relevant for modeling future dilution and executive pay schedules.